Contribution of serotype-specific IgG concentration, IgG subclasses and relative antibody avidity to opsonophagocytic activity against Streptococcus pneumoniae

Clinical and Experimental Immunology

Volumn 118, Issue 3, 1999, Pages 402-407

  Anttila, Merja ^a   Voutilainen, M ^a   Jantti V ^a   Eskola, J ^a   Kayhty H ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Conjugate vaccines; Opsonophagocytic activity; Streptococcus pneumoniae

Indexed keywords

IMMUNOGLOBULIN G; PNEUMOCOCCUS VACCINE;

ADULT; ANTIBODY AFFINITY; ANTIBODY DETECTION; ARTICLE; BACTERICIDAL ACTIVITY; CONCENTRATION RESPONSE; ENZYME IMMUNOASSAY; HUMAN; IMMUNIZATION; INFANT; MAJOR CLINICAL STUDY; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

ADULT; AGE FACTORS; ANTIBODIES, BACTERIAL; ANTIBODY SPECIFICITY; BACTERIAL CAPSULES; BACTERIAL VACCINES; BIOLOGICAL ASSAY; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN G; INFANT; OPSONIN PROTEINS; PHAGOCYTOSIS; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; TIME FACTORS;

EID: 0032739815     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.01077.x     Document Type: Article

References (24)

1. 1 Steinhoff MC, Edwards K, Keyserling H, Thoms ML, Johnson C, Madore D, Hogerman D. A randomized comparison of three bivalent Streptococcus pneumoniae glycoprotein conjugate vaccines in young children: effect of polysaccharide size and linkage characteristics. Pediatr Infect Dis J 1994; 13:368-72.
2. 2 Käyhty H, Åhman H, Rönnberg P-R, Tillikainen R, Eskola J. Pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine is immunogenic in infants and children. J Infect Dis 1995; 172:1273-8.
3. 3 Leach A, Ceesay SJ, Banya WA, Greenwood BM. Pilot trial of pentavalent pneumococcal polysaccharide/protein conjugate vaccine in Gambian infants. Pediatr Infect Dis J 1996; 15:333-9.
4. 4 Dagan R, Melamed R, Zamir O, Leroy O. Safely and immunogenicity of tetravalent pneumococcal vaccines containing 6B, 14, 19F and 23F polysaccharides conjugated to either tetanus or diphtheria toxoid in young infants and their boosterability by native polysaccharide antigens. Pediatr Infect Dis J 1997; 16:1053-9.
5. 5 Åhman H, Käyhty H, Lehtonen H, Leroy O, Froeschle J, Eskola J. Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid conjugate vaccine is immunogenic in early infancy and able to induce immunologic memory. Pediatr Infect Dis J 1998; 17:211-6.
6. 197 in United States infants. Pediatrics 1998; 101:604-11.
7. 7 Vidarsson G, Sigurdardottir ST, Gudnason T et al. Isotypes and opsonophagocytosis of pneumococcus type 6B antibodies elicited in infants and adults by an experimental pneumococcus type 6B-tetanus toxoid vaccine. Infect Immun 1998; 66:2866-70.
8. S Soininen A, Seppälä I, Nieminen T, Eskola J, Käyhty H. IgG subclass distribution of antibodies after vaccination of adults with pneumococcal conjugate vaccines. Vaccine 1999; 17:1889-97.
9. 9 Anttila M, Eskola J, Åhman H, Käyhty H. Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines. J Infect Dis 1998; 177:1614-21.
10. 10 Anttila M, Eskola J, Åhman H, Käyhty H. Differences in the avidity of antibodies evoked by four different pneumococcal conjugate vaccines in early childhood. Vaccine 1999; 17:1970-7.
11. 11 Nieminen T, Eskola J, Käyhty H. Pneumococcal conjugate vaccination in adults: circulating antibody secreting cell response and humoral antibody responses in saliva and in serum. Vaccine 1998; 16:630-6.
12. 12 Korkeila M, Lehtonen H, Åhman H, Leroy O, Eskola J, Käyhty H. Salivary anti-capsular antibodies in infants and children immunized with Streptococcus pneumoniae capsular polysaccharide-tetanus or diphtheria toxoid conjugate vaccines. Vaccine, in press.
13. 13 Dagan R, Rimma M, Muallem M et al. Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine. J Infect Dis 1996; 174:1271-8.
14. 14 Dagan R, Muallem M, Rimma M, Leroy O, Yagupsky P. Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid. Pediatr Infect Dis J 1997; 16:1060-4.
15. 15 Tuomanen EI, Austrian R, Masure HR. Pathogenesis of pneumococcal infection. N Engl J Med 1995; 332:1280-4.
16. 16 Quataert SA, Kirch CS, Wiedl LJ, Phipps DC, Strohmeyer S, Cimino CO, Skuse J, Madore DV. Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, Lot 89-S. Clin Diagn Lab Immunol 1995; 2:590-7.
17. 17 Soininen A, Seppälä I, Wuorimaa T, Käyhty H. Assignment of immunoglobulin G1 and G2 concentrations to pneumococcal capsular polysaccharides 3, 6B, 14, 19F, and 23F in pneumococcal reference serum 89-SF. Clin Diagn Lab Immunol 1998; 5:561-6.
18. 18 Romero-Steiner S, Libutti D, Pais LB, Dykes J, Anderson P, Whitin JC, Keyserling HL, Carlone GM. Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells. Clin Diagn Lab Immunol 1997; 4:415-22.
19. 19 Soininen A, van den Doppelsteen G, Oomen L, Käyhty H. Are there cross-reactive epitopes in Pnc capsular polysaccharides [Abstract P118]. In: International Symposium on Pneumococci and Pneumococcal Diseases, June, Helsingor, Denmark, 1998.
20. 20 Coughlin RT, White AC, Anderson CA, Carlone GM, Klein DL, Treanor J. Characterization of anti-pneumococcal antibodies in healthy unvaccinated adults [Abstract 41]. In: Pneumococcal Vaccines for the World Conference, October, Washington DC, USA, 1998.
21. 21 Nahm M, Xinhing Y. Pneumococcal polysaccharide vaccines may elicit antibodies that lack serotype specificity and opsonophagocytic capacity. [Abstract 36]. In: Pneumococcal Vaccines for the World Conference, October, Washington DC, USA, 1998.
22. 22 Ziembiec NA, Sikkema DJ, Hildreth SW, Quataert SA, Madore DV. Assignment of IgG1 and IgG2 concentrations to additional pneumococcal capsular polysaccharides in pneumococcal reference serum 89-SF. In: 99th General Meeting of American Society for Microbiology, May-June Chicago, Illinois, USA, 1999.
23. 23 Schlesinger Y, Granoff DM, Vaccine Study Group. Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. JAMA 1992; 267:1489-94.
24. 24 Vidarsson G, Jonsdottir I, Jonsson S, Valdimarsson H. Opsonization and antibodies to capsular and cell wall polysaccharides of Streptococcus pneumoniae. J Infect Dis 1994; 170:592-9.